Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-19 | 2023-10-04 | 195484 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194106 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194103 |
| TEVA-LEVETIRACETAM | 250MG | TABLET | Actual shortage | 2025-02-20 | 2026-01-15 | 250903 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-07-04 | 2024-09-19 | 232217 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2025-07-03 | 2025-12-18 | 261791 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195591 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-11-28 | 2022-08-18 | 99935 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-04-03 | 2017-11-07 | 5207 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94864 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-03-14 | 2017-11-07 | 2297 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Resolved | 2017-08-21 | 2018-02-22 | 19973 |
| TEVA-LEVOCARBIDOPA | 10MG 100MG | TABLET | Actual shortage | 2020-03-26 | 2020-03-26 | 109550 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-12-05 | 2022-08-18 | 100299 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Actual shortage | 2020-02-21 | 2020-03-26 | 106945 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Resolved | 2017-08-01 | 2018-02-22 | 17896 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140684 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
| TEVA-LIOTHYRONINE | 25MCG | TABLET | Actual shortage | 2025-12-11 | 2026-01-22 | 274021 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Resolved | 2017-03-14 | 2017-05-10 | 2312 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |